Chronic exposure to the copper-chelating agent, cuprizone (CPZ), is an increasingly popular model for producing demyelination. More importantly, cessation of cuprizone exposure allows for full remyelination, which represents a window of opportunity for determining the influence of environmental factors on regenerative processes. In the present study, CPZ-treated animals were assessed for functional status of systemic and central cytokine responsiveness to LPS, as well as assessment for signs of body weight changes. Exposure of male C57BL/6J mice to 5 weeks of 0.2% CPZ in the diet was optimal in producing demyelination and microglial activation, as measured by myelin basic protein, CD11b, and CD45 immunohistochemistry. Acute challenge with LPS at the end of 5 weeks CPZ treatment did not alter IL-1b, IL-6, nor TNFa responses in the spleen and corpus callosum. Similarly, repeated exposure to LPS during the remyelination phase (CPZ removal) did not influence these measures to LPS. Plasma corticosterone was unaffected following acute challenge of CPZ-pretreated animals, but after repeated LPS treatment, there was a significant augmentation of the corticosterone response in CPZ-pretreated mice. Interestingly, the basal concentration of IL-1b in the corpus callosum of CPZ treated animals was significantly increased, which was in keeping with the increase in activated microglial cells. In conclusion, the cuprizone model of demyelination and remyelination does not appear to influence the systemic nor central IL-1, IL-6, and TNF responses to acute nor repeated LPS. This opens up the possibility for studying the contribution of systemic inflammatory processes on remyelination after cessation of CPZ treatment.
Introduction
Multiple Sclerosis (MS) is a progressive, neurodegenerative disease of the central nervous system (CNS). It occurs most often in a relapsing/remitting form, in which a period of demyelination is followed by a period of functional recovery. The stage of recovery involves the generation of new oligodendrocytes, but as the disease progresses the ability to regenerate these cells fails and there is continuous pathology with loss of function (Keirstead and Blakemore, 1999) . The etiology of this disease remains unclear, although infectious agents such as Epstein-Barr virus (EBV), human herpes virus 6 (HHV-6), and Chlamydia pneumonia have been linked to MS (Hunter and Hafler, 2000) , in addition to genetic susceptibility and cellmediated autoimmunity (Oksenberg and Barcellos, 2005; Huseby et al., 2001; Ewing and Bernard, 1998) .
The most popular model for investigating MS and/or demyelinating disease is experimental allergic encephalomyelitis (EAE), wherein the focus is on autoreactive T lymphocytes, CNS infiltrating leukocytes and cytokine production (Vipin, 2004) . However, while EAE focuses on immunologically-induced demyelination and neurological impairment, alternative neurotoxicant-based models have been utilized to induce demyelination and, upon removal of the neurotoxicant, initiate a process of oligdendrocyte
